Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study was terminated in Australia. It focuses on ADHD.
In MelbourneThis study is completed in the United States. It is testing TAK-063 for schizophrenia.
Multiple locations, including Springdale
This study is completed in Canada. It is testing MDMA-Assisted Cognitive Processing Therapy (CPT) for PTSD.
In TorontoThis study was terminated in the United States. It focuses on ADHD.
Multiple locations, including Maitland
This study is ongoing in the United Kingdom and . It is testing Multiple Oral Doses of TAK-831 for Schizophrenia.
In United KingdomThis study is completed in the United States. It is testing Safety and Efficacy of CTP-692 for schizophrenia.
Multiple locations, including Little RockThis study is completed in the United Kingdom, in Germany, and . It is testing Safety and Efficacy of BIIB104 for schizophrenia.
In GermanyThis study is completed. It focuses on PTSD and currently lists study information in the United States and the United Kingdom.
Multiple locations, including BellflowerThis study was terminated in the United States. It is testing TNX-102 SL for PTSD.
Multiple locations, including PhoenixThis study is active but not recruiting in the United States, in France, in the United Kingdom, .... It focuses on anxiety.
Multiple locations, including Little RockThis study is active but not recruiting in the United States. It focuses on anxiety.
Multiple locations, including GilbertThis study is active but not recruiting in the United States. It focuses on depression.
Multiple locations, including FayettevilleHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.